Issuer-Sponsored by Tiziana Life Sciences*

TODAY’S TOP ALERT! 

Nasdaq: TLSA

Hey Folks!

I hope you’re having an awesome trading day.

It feels like Groundhog Day in the market with the S&P 500 and Nasdaq again setting new highs.

The Nasdaq Composite may even close up a full percent today.

Still, that will pale in comparison to the  “tactical trade” idea I sent out this morning, which has ripped more than 17% higher on the day:

Zooming out, I mentioned this morning that the stock had been funneling into an ever-more-narrow wedge over the past several months, and that the right news could cause a breakout to the upside.

TLSA chart before the opening bell.

Last night, I found chatter on some forums that suggested just the right news might be dropping imminently…

Sure enough, the company delivered this morning with the announcement of a big expansion on its Phase 2 clinical trial to include prestigious institutions such as:

• Yale University

• Johns Hopkins University

• Cornell University

• University at Buffalo (SUNY)

• University of Massachusetts (UMass)

• Thomas Jefferson University

As the company noted:

“These universities represent leaders in medical research and neurology, with a history of pioneering studies in multiple sclerosis. Their inclusion enhances the trial's reach and brings together top-tier expertise with innovative facilities to evaluate Tiziana’s promising approach to addressing [secondary progressive multiple sclerosis].”

This is exactly the sort of news the stock needed to break out of the wedge formation.

If you take a look at the six-month chart, though, you’ll see that it has only just hit escape velocity.

And on the one-day chart, you’ll see that it is really picking up steam as the day goes on.

All that to say: I think this one still has room to run.

Be sure TLSA is at the very top of your watchlist as we head toward the closing bell!

To Your Success,

Jeff Bishop

Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull

*Issuer Paid Content.  Just so you know, what you're reading is curated content for which we have received a monetary fee (detailed below) to create and distribute. Let's be clear that investing can be quite the roller coaster as stock prices can have wild swings up and down, so consider those crucial risks before you ever consider trading anything we discuss. Make sure you check out our full disclosure down below for the details on how we were paid, the risks, and why these results aren't what you'd call “typical.”

Just a quick heads up about this ad you're reading—as we’ve said, even though we like the company referenced above, and all the facts we discussed above are true to the best of our knowledge, we are running a business here. To distribute this information and help offset the costs of maintaining our large digital audience, in advance of writing the content above, we were paid thirty five thousand dollars directly from  Tiziana Life Sciences Ltd for a one day marketing program on December 4, 2024. Previously, we were paid thirty thousand dollars directly from  Tiziana Life Sciences Ltd for a one-day marketing program on October 30, 2024. We also received seventeen thousand five hundred dollars (cash) from Interactive Offers for advertising Tiziana Life Sciences Ltd for a one day marketing program on June 6, 2024. Before that, we were paid seventeen thousand five hundred dollars (cash) from Interactive Offers for advertising Tiziana Life Sciences Ltd for a one day marketing program on April 22, 2024. Also, keep in mind that due to the sheer size of our audience, if even a small percentage of people decide they want to buy this stock, it could potentially boost interest enough to hike up those share prices and cause a temporary spike, and the opposite is possible as our program ends, though that is not always the case.

Now, diving right into  Tiziana Life Sciences Ltd might sound exciting. But remember, it’s like venturing into the wilderness—be aware that there's exceptional risk involved in trading. This isn't small potatoes we're talking about; you could lose every dime you put in, so always carefully think about what you’re doing. That’s why they call this trading, after all. We're shining a light on the good stuff about the company here, but it's on you to do your homework, make your own calls, and determine a plan for your own trading, hopefully with the help of your professional 1nvestment advis0r.

Oh, that brings us to another crucial point—we're not here to tell you (or even recommend) what you should do with your hard-earned money. We’re simply sharing our non-expert thoughts by highlighting some companies we like that could use some help telling their story to more people. We’re obviously biased in our writing. We’re not here to dig into anything that may be negative about the company; this is advertising, after all! Also, keep in mind that if we make some predictions about the future, these are technically known as “forward-L00king statements” under the securities acts, so take those with a grain of salt. As with all forecasts, they’re not set in stone, often wrong, and we certainly can’t know where the Company’s earnings, business, or share price will be tomorrow or a year from now.

Everything you read from us is all for your education, information, and possible entertainment. While we believe the info is reliable and accurate, we can't wear a cape and guarantee it. Before you jump into anything, make sure to talk it over with a pro—someone you trust who's licensed to give you real advice. To be clear, 

Neither Raging Bull nor its owners, employees, or independent contractors are registered as a secur1.ties br0ker-deale.r, br0ker, 1nvest.ment advis0r (IA), or IA rep’s with the SEC, any state securities regulat0ry auth.ority, or any self-regulat0ry organization.

So, that's the scoop! If you're intrigued and want to learn more about the companies we talk about, hit up the SEC's website to dig into their filings and see the full picture.